These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2435688)

  • 1. Effects of nucleoside analogs and sodium butyrate on recovery from potentially lethal X ray damage in human colon tumor cells.
    Arundel CM; Leith JT
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):593-601. PubMed ID: 2435688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of the differentiating agent sodium butyrate on recovery processes after x-irradiation in heterogeneous human colon tumor cells.
    Arundel CM; Kenney SM; Leith JT; Glicksman AS
    Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):959-68. PubMed ID: 3721937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB).
    Arundel CM; Glicksman AS; Leith JT
    Radiat Res; 1985 Dec; 104(3):443-8. PubMed ID: 4080986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the differentiating agents sodium butyrate and N-methylformamide on the oxygen enhancement ratio of human colon tumor cells.
    Hallows KR; Bliven SF; Leith JT
    Radiat Res; 1988 Jan; 113(1):191-8. PubMed ID: 3340722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells.
    Côté S; Momparler RL
    Anticancer Drugs; 1997 Jan; 8(1):56-61. PubMed ID: 9147612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of N,N-dimethylformamide on sublethal and potentially lethal damage recovery processes after X-irradiation in heterogeneous human colon tumor cells.
    Arundel CM; Glicksman AS; Leith JT
    Cancer Res; 1985 Nov; 45(11 Pt 1):5557-62. PubMed ID: 4053029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.
    Du HL; Ren LM; Chen H; Zhu Y; Qi Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):981-4. PubMed ID: 12433622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in X-ray sensitivity and glutathione content of human colon tumor cells after exposure to the differentiation-inducing agent sodium butyrate.
    Leith JT; Hallows KT; Arundel CM; Bliven SF
    Radiat Res; 1988 Jun; 114(3):579-88. PubMed ID: 3375444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines.
    Cho HJ; Kim SY; Kim KH; Kang WK; Kim JI; Oh ST; Kim JS; An CH
    World J Surg Oncol; 2009 May; 7():49. PubMed ID: 19460134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of X ray sensitivity by combinations of sodium butyrate and buthionine sulfoximine.
    Leith JT
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):949-51. PubMed ID: 3182335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells.
    Qiu H; Yashiro M; Shinto O; Matsuzaki T; Hirakawa K
    Cancer Sci; 2009 Jan; 100(1):181-8. PubMed ID: 19037991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antineoplastic activity of adozelesin alone and in combination with 5-aza-2'-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cells.
    Côté S; Momparler RL
    Anticancer Drugs; 1993 Jun; 4(3):327-33. PubMed ID: 7689364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines.
    Carpinelli P; Granata F; Augusti-Tocco G; Rossi M; Bartolucci S
    Anticancer Drugs; 1993 Dec; 4(6):629-35. PubMed ID: 7507741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR; Moore BC; Ririe TO; Jones DA
    Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.
    Abbruzzese JL; Frost P
    Cancer Chemother Pharmacol; 1992; 30(1):31-6. PubMed ID: 1375133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M; Momparler LF; Raynal NJ; Bernstein ML; Momparler RL
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nutritional state on the expression of radiation injury in two tumor subpopulations obtained from a heterogeneous human colon carcinoma.
    Arundel CM; Leith JT
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):59-67. PubMed ID: 3943993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.
    Momparler RL; Laliberté J
    Leuk Res; 1990; 14(9):751-4. PubMed ID: 1700230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-aza-2'-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cells.
    Doré BT; Momparler RL
    Anticancer Drugs; 1992 Jun; 3(3):281-7. PubMed ID: 1381972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
    Momparler RL; Doré BT; Momparler LF
    Cancer Lett; 1990 Oct; 54(1-2):21-8. PubMed ID: 1698532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.